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Background
Antibodies broadly neutralizing HIV-1 such as 2F5 and
4E10 recognize one epitope in the membrane-proximal
external region (MPER) of the HIV transmembrane enve-
lope (TM) protein gp41 MPER of gp41 (ELDKWA,
NWF(D/N)IT, respectively). We reported previously, that
immunizing with the TM protein of different gammaret-
roviruses such as the porcine endogenous retrovirus,
PERV, and the feline leukemia virus, FeLV, neutralizing
antibodies were obtained, that recognized two epitopes.
One epitope was located in the fusion peptide-proximal
region (FPPR) (epitope 1, E1), the other in the MPER of
p15E (E2). E2 of gammaretroviruses was similarly located
as NWF(D/N)IT (E2) of HIV-1 and despite the evolution-
ary separation of HIV and gammaretroviruses, an unex-
pected sequence homology was observed in this region
(epitope FEGWFN) (Fiebig et al., Virology, 307,406,
2003; Langhammer et al., Immunology, 117, 229, 2005;
Vaccine, 23, 3341, 2005). We also reported identification
of an E1 region in gp41 of HIV-1 located similarly as E1 of
gammaretroviruses (Fiebig et al., AIDS, 23, 887, 2009)
and enhancing the binding of 2F5 and 4E10 to their
epitopes in E2.
Methods
To study the interaction of the neutralizing antibodies
with their epitopes in more detail, surface plasmon reso-
nance (SPR) analyzes were performed.
Results
Using this technology, binding of the antibodies neutral-
izing PERV to PERV-derived E1 and E2 and of 2F5 and
4E10 to HIV-derived E2 was confirmed. Whereas a direct
interaction between E1 and E2 of HIV-1 was observed,
this was not the case with E1 and E2 of PERV.
Conclusion
Detailed analyzes of the interaction between E1 and E2
and the corresponding neutralizing antibodies may help
to define conformations required for the induction of
broadly neutralizing antibodies.
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